alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
```

[Congressional Bills 109th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 826 Introduced in House (IH)]

109th CONGRESS
  2d Session
H. RES. 826

 Expressing the sense of the House of Representatives that a National 
                Youth Sports Week should be established.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                              May 19, 2006

 Mr. McIntyre (for himself, Mr. Hulshof, Mr. Van Hollen, Mr. Kind, Mr. 
 Pickering, Mr. Chandler, Mr. Wamp, Mr. Tiahrt, and Mr. Bradley of New 
 Hampshire) submitted the following resolution; which was referred to 
                   the Committee on Government Reform

_______________________________________________________________________

                               RESOLUTION

 
 Expressing the sense of the House of Representatives that a National 
                Youth Sports Week should be established.

Whereas about 42 million children participate in organized sports each year;
Whereas children participating in organized sports tend to perform better in 
        school, develop excellent interpersonal skills, and lead healthier 
        lives;
Whereas organized youth sports help children increase their self-esteem, develop 
        an appreciation of health and fitness, and become leaders within the 
        community;
Whereas organized youth sports provide for regular physical activity and help 
        combat increasing rates of childhood obesity;
Whereas the Congressional Caucus on Youth Sports was created, with great help 
        and support from the Citizenship Through Sports Alliance, Positive 
        Coaching Alliance, and National Recreation and Park Association, to 
        restore the focus in youth sports on the child's experience and 
        character development;
Whereas far too many children quit participating in youth sports at a young age, 
        many telling coaches and parents, ``It just wasn't fun anymore'';
Whereas the National Recreation and Park Association has designated July as 
        Parks and Recreation Month;
Whereas many youth sports organizations gather at local parks and recreation 
        facilities across the country; and
Whereas designating the second week in July as National Youth Sports Week would 
        raise awareness of the important physical and emotional benefits of 
        participating in youth sports and the need to promote sportsmanship 
        among players, parents, coaches, and officials: Now, therefore, be it
    Resolved,  That it is the sense of the House of Representatives 
that a National Youth Sports Week should be established to promote 
awareness of the importance of youth sports and the need to restore the 
focus in youth sports on the child's experience and character 
development.
                                 <all>
```
Exhibit 31.1

CERTIFICATION UNDER SECTION 302 OF THE
SARBANES-OXLEY ACT OF 2002

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

I, Richard Leeds, Chief Executive Officer of Systemax
Inc., certify that:

1. I have reviewed this annual report on Form 10-K of
Systemax Inc. (the "registrant");

2. Based on my knowledge, this annual report does not
contain any untrue statement of a material fact or omit to state a material fact
necessary to make the statements made, in light of the circumstances under which
such statements were made, not misleading with respect to the period covered by
this annual report;

3. Based on my knowledge, the financial statements,
and other financial information included in this annual report, fairly present
in all material respects the financial condition, results of operations and cash
flows of the registrant as of, and for, the periods presented in this annual
report;

4. The registrant's other certifying officer and I
are responsible for establishing and maintaining disclosure controls and
procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the
registrant and we have:

a) designed such disclosure controls and procedures,
or caused such disclosure controls and procedures to be designed under our
supervision, to ensure that material information relating to the registrant,
including its consolidated subsidiaries, is made known to us by others within
these entities, particularly during the period in which this annual report is
being prepared;

b) evaluated the effectiveness of the registrant's disclosure controls and
procedures and presented in this report our conclusions about the effectiveness
of the disclosure controls and procedures, as of the end of the period covered
by this report based on such evaluation; and

c) disclosed in this report any change in the
registrant's internal control over financial reporting that occurred during the
registrant's fourth fiscal quarter that has materially affected, or is
reasonably likely to materially affect, the registrant's control over financial
reporting.

5. The registrant's other certifying officer and I
have disclosed, based on our most recent evaluation of internal control over
financial reporting, to the registrant's auditors and the audit committee of the
registrant's board of directors:

a) all significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting known to me which are
reasonably likely to adversely affect the registrant's ability to record,
process, summarize and report financial information; and

b) any fraud, whether or not material, that involves
management or other employees who have a significant role in the registrant's
internal controls over financial reporting.

Date: March 26, 2004

/s/ RICHARD LEEDS
Richard Leeds, Chief Executive Officer
#### § 1309.63 Transfer of registration.

No registration or any authority conferred thereby shall be assigned or otherwise transferred except upon such conditions as the Administrator may specifically designate and then only pursuant to his written consent.
<PAGE>
 
                                                                     EXHIBIT 23
 
                      CONSENT OF INDEPENDENT ACCOUNTANTS
 
  We consent to the incorporation by reference in the registration statements
of Raptor Systems, Inc. and its wholly owned subsidiaries on all Forms S-8
(Commission File # 33-03146, filed April 3, 1996) in effect on the filing date
of Raptor Systems, Inc.'s Annual Report on Form 10-K for the year ended
December 31, 1996 of our report dated January 28, 1997, on our audits of the
consolidated financial statements of Raptor Systems, Inc. and its wholly owned
subsidiaries as of December 31, 1996 and 1995, and for the years ended
December 31, 1996, 1995 and 1994, which report is included or incorporated by
reference in this Annual Report on Form 10-K.
 
Coopers & Lybrand L.L.P.
 
Boston, Massachusetts
March 19, 1997
Editorial Note on Part 12
Editorial Note: Nomenclature changes to part 12 appear at 88 FR 45064, July 14, 2023.

§ 12.95 Official notice. ( a ) Official notice may be taken of such matters as might be judicially noticed by the courts of the United States or of any other matter peculiarly within the general knowledge of FDA as an expert agency.
( b ) If official notice is taken of a material fact not appearing in the evidence of record, a participant, on timely request, will be afforded an opportunity to show the contrary.
[Cite as McLeod v. Ohio Dept. of Rehab. & Corr. , 2011-Ohio-1851.] 

# Court of Claims of Ohio

The Ohio Judicial Center 65 South Front Street, Third Floor Columbus, OH 43215 614.387.9800 or 1.800.824.8263 www.cco.state.oh.us

ALBERT MCLEOD, III

Plaintiff

v.

OHIO DEPARTMENT OF REHABILITATION AND CORRECTION

Defendant Case No. 2009-04220

Judge Joseph T. Clark Magistrate Matthew C. Rambo

JUDGMENT ENTRY

{¶ 1} On January 31, 2011, the magistrate issued a decision recommending judgment for plaintiff. {¶ 2} Civ.R. 53(D)(3)(b)(i) states, in part: “A party may file written objections to a magistrate’s decision within fourteen days of the filing of the decision, whether or not the court has adopted the decision during that fourteen-day period as permitted by Civ.R. 53(D)(4)(e)(i).” No objections were filed. {¶ 3} The court determines that there is no error of law or other defect evident on the face of the magistrate’s decision. Therefore, the court adopts the magistrate’s decision and recommendation as its own, including findings of fact and conclusions of law contained therein. Judgment is rendered for plaintiff. The case is ready to be set for trial on the issue of damages.

_____________________________________ JOSEPH T. CLARK Judge

cc:Case No. 2009-04220 - 2 - ENTRY

Christopher P. Conomy A ssistant Attorney General 150 East Gay Street, 18th Floor Columbus, Ohio 43215-3130 Richard F. Swope 6480 East Main Street, Suite 102 Reynoldsburg, Ohio 43068

MR/cmd / Filed March 23, 2011/To S.C. reporter April 12, 2011
#### § 1230.31 Where samples may be collected.

Caustic or corrosive substances within the scope of this act (44 Stat. 1406; 15 U.S.C. 401-411) may be sampled wherever found.
# EUR-Lex - 31984D0375 - EN

Avis juridique important

*|*

# 31984D0375

**84/375/EEC: Commission Decision of 5 July 1984 amending Decision 83/471/EEC relating to the Community Inspection Committee on the application of the classification scale for carcases of adult bovine animals **

*
Official Journal L 196 , 26/07/1984 P. 0053 - 0053 Finnish special edition: Chapter 3 Volume 17 P. 0232 Spanish special edition: Chapter 03 Volume 31 P. 0193 Swedish special edition: Chapter 3 Volume 17 P. 0232 Portuguese special edition Chapter 03 Volume 31 P. 0193 *

*****

COMMISSION DECISION

of 5 July 1984

amending Decision 83/471/EEC relating to the Community Inspection Committee on the application of the classification scale for carcases of adult bovine animals

(84/375/EEC)

THE COMMISSION OF THE EUROPEAN

COMMUNITIES,

Having regard to the Treaty establishing the European Economic Community,

Having regard to Council Regulation (EEC) No 1208/81 of 28 April 1981 determining the Community scale for the classification of carcases of adult bovine animals (1), and in particular the fourth paragraph of Article 5 thereof,

Whereas Commission Decision 83/471/EEC (2) laid down detailed rules for the conduct of on-the-spot inspections by the Community Inspection Committee referred to in Article 5 of Regulation (EEC) No 1208/81;

Whereas, by Regulation (EEC) No 869/84 (3), the Council decided to apply, for a three-year experimental period, intervention measures on the basis of the Community classification scale established under Regulation (EEC) No 1208/81; whereas the scope of the inspections carried out by the Inspection Committee should be extended so as also to cover the classification, identification and marking of products which are the subject of intervention measures; whereas, in consequence, Decision 83/471/EEC should therefore be amended,

HAS ADOPTED THIS DECISION:

Article 1

Decision 83/471/EEC is hereby amended as follows:

1. Article 1 is replaced by the following:

'Article 1

The Community Inspection Committee provided for in Article 5 of Regulation (EEC) No 1208/81, hereinafter referred to as 'the Committee', shall be responsible for carrying out on-the-spot inspections covering:

(a) the application of the arrangements relating to the Community classification scale for carcases of adult bovine animals;

(b) the recording of market prices according to the classification scale;

(c) the classification, identification and marking of products within the framework of the intervention measures provided for in Article 5 of Regulation (EEC) No 805/68.'

2. Article 3 (1) is replaced by the following:

'1. On-the-spot inspections shall be carried out at abattoirs, meat markets, intervention centres, price quotation centres and regional and central services engaged in the implementation of the provisions referred to in Article 1.'

Article 2

This Decision is addressed to the Member States.

Done at Brussels, 5 July 1984.

For the Commission

Poul DALSAGER

Member of the Commission

(1) OJ No L 123, 7. 5. 1981, p. 3.

(2) OJ No L 259, 20. 9. 1983, p. 30.

(3) OJ No L 90, 1. 4. 1984, p. 32.
exv10w01



 




Exhibit
10.01
















			
	Company Contacts:	 	Charlie Webster

Vice President, Finance

(408) 875-5061

Charlie.webster@kla-tencor.com


Kyra Whitten (Media)

Sr. Director, Corporate Communications

(408) 875-7819

Kyra.whitten@kla-tencor.com










FOR IMMEDIATE RELEASE




KLA-TENCOR DECLARES REGULAR CASH DIVIDEND FOR

FIRST QUARTER FISCAL YEAR 2007




SAN JOSE, Calif., August 3, 2006—KLA-Tencor Corporation (NASDAQ: KLAC) today announced that
its board of directors has declared a quarterly cash dividend of $.12 per share on its common stock
payable on September 1, 2006 to KLA-Tencor stockholders of record on August 15, 2006.



About KLA-Tencor: KLA-Tencor is the world leader in yield management and process control
solutions for semiconductor manufacturing and related industries. Headquartered in San Jose,
Calif., the company has sales and service offices around the world. An S&P 500 company, KLA-Tencor
is traded on the Nasdaq National Market under the symbol KLAC. Additional information about the
company is available on the Internet at http://www.kla-tencor.com



###
* Pursuant to 5 TH C IR . R. 47.5, the Court has determined that this opinion should not be published and is not precedent except under the limited circumstances set forth in 5 TH C IR . R. 47.5.4. United States Court of Appeals Fifth Circuit 

## FILED April 9, 2003 Charles R. Fulbruge III Clerk IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

No. 02-60345 Summary Calendar

JOSE CARLOS AVILA, Petitioner,

versus JOHN ASHCROFT, UNITED STATES ATTORNEY GENERAL, Respondent.

Petition for Review of an Order of the Board of Immigration Appeals (BIA No. A74 654 026)

_______________________________________________________ Before REAVLEY, BARKSDALE and CLEMENT, Circuit Judges. PER CURIAM: * 

### Jose Avila appeals the decision of the Board of Immigration Appeals which denied his request for cancellation of removal under 8 U.S.C. § 1229b(b). We do not have jurisdiction to review this decision. Title 8 U.S.C. § 1252(a)(2)(B) expressly provides2



### that no court has jurisdiction to review “[d]enials of discretionary relief,” including requests for relief under § 1229b. Avila’s argument that this provision only applies when relief is granted is rejected. PETITION DISMISSED.
§ 376.995 Principal (HHS supplement to government-wide definition at 2 CFR 180.995). *Principal* means individuals, in addition to those listed at 2 CFR 180.995, who participate in HHS covered transactions including: ( a ) Providers of federally required audit services; and
( b ) Researchers.
Editorial Note on Part 180
Editorial Note: Nomenclature changes to part 180 appear at 79 FR 75879, Dec. 19, 2014.

§ 180.335 What information must I provide before entering into a covered transaction with a Federal agency? Before you enter into a covered transaction at the primary tier, you as the participant must notify the Federal agency office that is entering into the transaction with you, if you know that you or any of the principals for that covered transaction: ( a ) Are presently excluded or disqualified;
( b ) Have been convicted within the preceding three years of any of the offenses listed in § 180.800(a) or had a civil judgment rendered against you for one of those offenses within that time period;
( c ) Are presently indicted for or otherwise criminally or civilly charged by a governmental entity (Federal, State or local) with commission of any of the offenses listed in § 180.800(a); or
( d ) Have had one or more public transactions (Federal, State, or local) terminated within the preceding three years for cause or default.
§ 910.510 Financial statements. ( a ) *Financial statements.* If available, the auditee must submit financial statements that reflect its financial position, results of operations or changes in net assets, and, where appropriate, cash flows for the fiscal year audited. The financial statements must be for the same organizational unit and fiscal year that is chosen to meet the requirements of this Part. However, for-profit entity-wide financial statements may also include departments, agencies, and other organizational units that have separate audits in accordance with § 910.514 Scope of audit, paragraph (a) and prepare separate financial statements.
( b ) *Schedule of expenditures of DOE awards.* The auditee must prepare a schedule of expenditures of DOE awards for the period covered by the auditee's fiscal year which must include the total DOE awards expended as determined in accordance with § 910.502 Basis for determining DOE awards expended. While not required, the auditee may choose to provide information requested by DOE and pass- through entities to make the schedule easier to use. For example, when a DOE program has multiple DOE award years, the auditee may list the amount of DOE awards expended for each DOE award year separately. At a minimum, the schedule must: ( 1 ) List individual DOE programs. For a cluster of programs, provide the cluster name, list individual DOE programs within the cluster of programs. For R&D, total DOE awards expended must be shown by individual DOE award and major subdivision within DOE. For example, the National Institutes of Health is a major subdivision in the Department of Health and Human Services.
( 2 ) Not applicable.
( 3 ) Provide total DOE awards expended for each individual DOE program and the CFDA number For a cluster of programs also provide the total for the cluster.
( 4 ) Not applicable.
( 5 ) Not applicable.
( 6 ) Include notes that describe that significant accounting policies used in preparing the schedule, and note whether or not the for-profit entity elected to use the 10% de minimis cost rate as covered in 2 CFR 200.414 Indirect (F&A) costs.
#### § 1005.3 Importation of noncomplying goods prohibited.

The importation of any electronic product for which standards have been prescribed under section 534 of the Federal Food, Drug, and Cosmetic Act (the act) (21 U.S.C. 360kk) shall be refused admission into the United States unless there is affixed to such product a certification in the form of a label or tag in conformity with section 534(h) of the act (21 U.S.C. 360kk(h)). Merchandise refused admission shall be destroyed or exported under regulations prescribed by the Secretary of the Treasury unless a timely and adequate petition for permission to bring the product into compliance is filed and granted under §§ 1005.21 and 1005.22.

[69 FR 11314, Mar. 10, 2004]
§ 121.330 Use of existing records. ( a ) Existing records (*e.g.,* records that are kept to comply with other Federal, State, or local regulations, or for any other reason) do not need to be duplicated if they contain all of the required information and satisfy the requirements of this subpart. Existing records may be supplemented as necessary to include all of the required information and satisfy the requirements of this subpart.
( b ) The information required by this part does not need to be kept in one set of records. If existing records contain some of the required information, any new information required by this part may be kept either separately or combined with the existing records.
§ 1271.65 How do I store an HCT/P from a donor determined to be ineligible, and what uses of the HCT/P are not prohibited? ( a ) *Storage.* If you are the establishment that stores the HCT/P, you must store or identify HCT/Ps from donors who have been determined to be ineligible in a physically separate area clearly identified for such use, or follow other procedures, such as automated designation, that are adequate to prevent improper release until destruction or other disposition of the HCT/P in accordance with paragraph (b) or (c) of this section.
( b ) *Limited uses of HCT/P from ineligible donor.* ( 1 ) An HCT/P from a donor who has been determined to be ineligible, based on the results of required testing and/or screening, is not prohibited by subpart C of this part from use for implantation, transplantation, infusion, or transfer under the following circumstances: ( i ) The HCT/P is for allogeneic use in a first-degree or second-degree blood relative;
( ii ) The HCT/P consists of reproductive cells or tissue from a directed reproductive donor, as defined in § 1271.3(l); or
( iii ) There is a documented urgent medical need as defined in § 1271.3(u).
( 2 ) You must prominently label an HCT/P made available for use under the provisions of paragraph (b)(1) of this section with the Biohazard legend shown in § 1271.3(h) with the statement “WARNING: Advise patient of communicable disease risks,” and, in the case of reactive test results, “WARNING: Reactive test results for (name of disease agent or disease).” The HCT/P must be accompanied by the records required under § 1271.55.
( 3 ) If you are the establishment that manufactured an HCT/P used under the provisions of paragraph (b)(1) of this section, you must document that you notified the physician using the HCT/P of the results of testing and screening.
( c ) *Nonclinical use.* You may make available for nonclinical purposes an HCT/P from a donor who has been determined to be ineligible, based on the results of required testing and/or screening, provided that it is labeled: ( 1 ) “For Nonclinical Use Only” and
( 2 ) With the Biohazard legend shown in § 1271.3(h).
§ 910.513 Responsibilities. ( a ) ( 1 ) Not applicable.
( 2 ) Not applicable.
( 3 ) Not applicable. ( i ) Not applicable.
( ii ) Not applicable.
( iii ) Not applicable.
( iv ) Not applicable.
( v ) Not applicable.
( vi ) Not applicable.
( vii ) Not applicable.
( viii ) Not applicable.
( ix ) Not applicable.
( b ) Not applicable. ( 1 ) Not applicable.
( 2 ) Not applicable.
( c ) *DOE responsibilities.* DOE must perform the following for the awards it makes (See also the requirements of 2 CFR 200.211 Information contained in a Federal award): ( 1 ) Ensure that audits are completed and reports are received in a timely manner and in accordance with the requirements of this Part.
( 2 ) Provide technical advice and counsel to auditees and auditors as requested.
( 3 ) Follow-up on audit findings to ensure that the recipient takes appropriate and timely corrective action. As part of audit follow-up, the DOE must: ( i ) Issue a management decision as prescribed in § 910.521 Management decision;
( ii ) Monitor the recipient taking appropriate and timely corrective action;
( iii ) Use cooperative audit resolution mechanisms (see 2 CFR 200.1, Cooperative audit resolution) to improve DOE program outcomes through better audit resolution, follow-up, and corrective action; and
( iv ) Develop a baseline, metrics, and targets to track, over time, the effectiveness of the DOE's process to follow-up on audit findings and on the effectiveness of Compliance Audits in improving non-Federal entity accountability and their use by DOE in making award decisions.
( 4 ) Not applicable.
( 5 ) Not applicable. ( i ) Not applicable.
( ii ) Not applicable.
( 6 ) Not applicable.
( 7 ) Not applicable. ( i ) Not applicable.
( ii ) Not applicable.
( iii ) Not applicable.
( iv ) Not applicable.
( v ) Not applicable.
( vi ) Not applicable.
( vii ) Not applicable.
( viii ) Not applicable.
[79 FR 76024, Dec. 19, 2014, as amended at 87 FR 15321, Mar. 18, 2022]
#### § 1230.33 Investigations.

Authorized agents in the employ of the Department of Health and Human Services may make investigations, including the inspection of premises where dangerous caustic and corrosive substances subject to the act are manufactured, packed, stored, or held for sale or distribution, and make examinations of freight and other transportation records.